Protein may prevent transformation from MDS to AMLMarch 28, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Selinexor trials placed on partial holdMarch 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyAMLNon-Hodgkin LymphomaAggressive Lymphomas
Study reveals higher rate of early death in kids with cancerMarch 7, 2017Leukemia, Myelodysplasia, TransplantationPediatricsAMLALL
Drug granted priority review for relapsed/refractory AMLMarch 2, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Docs create guideline to aid workup of acute leukemiaFebruary 24, 2017Leukemia, Myelodysplasia, TransplantationAMLALL
Model illustrates progression to MDS, AMLFebruary 21, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Site of care may impact survival for AYAs with ALL, AMLFebruary 17, 2017Leukemia, Myelodysplasia, TransplantationAMLALL
Styrene exposure linked to myeloid leukemia, HLFebruary 16, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLHodgkin LymphomaCMLAggressive Lymphomas
Group identifies ‘essential’ genes in AMLFebruary 12, 2017Leukemia, Myelodysplasia, TransplantationAML
Computer predicts remission, relapse in AMLFebruary 10, 2017Leukemia, Myelodysplasia, TransplantationAML
Azathioprine may increase risk of MDS, AMLFebruary 7, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Company reports third death in SL-401 trialFebruary 4, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAML
Targeting disease stem cells in AML, MDSJanuary 31, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
